SCHEMBL23770719

SCHEMBL23770719

Cc1ccc(F)cc1-c1nc(NSc2cccc(N3CCN4CCC3C4)n2)ccc1C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19925114 0.83 SCN1A (0.35) IRAK4
SCHEMBL29464445 0.83 SCN1A (0.35) IRAK4
SCHEMBL23770452 0.82 PDE10A (0.34)
SCHEMBL23770466 0.81 CYP1A2 (0.37)
SCHEMBL23770431 0.81 GHSR (0.36)
SCHEMBL23770770 0.80 ADRB2 (0.38)
SCHEMBL23770791 0.80 PRKCQ (0.34)
SCHEMBL23770889 0.79 WDR5 (0.31)
SCHEMBL23770640 0.79 ITGB2 (0.40)
SCHEMBL19968845 0.78 NR1H2 (0.33) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed